[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ladrx Corp (LADX)

Ladrx Corp (LADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ladrx Corp 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 USA

www.ladrxcorp.com Employees: 2 P: 310-826-5648

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

LadRx Corporation is a biopharmaceutical company. It engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. LadRx Corporation, formerly known as CytRx Corporation, is based in Los Angeles, California.

Key Statistics

Overview:

Market Capitalization, $K 53
Enterprise Value, $K -708
Shares Outstanding, K 500
Float, K 460
% Float 91.90%
Short Interest, K 0
Short Float 0.00%
Days to Cover 9.47
Short Volume Ratio 1.00
% of Insider Shareholders 8.10%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -1,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -720 K
EBIT, $ -3,500 K
EBITDA, $ -3,490 K

Growth:

1-Year Return -93.64%
3-Year Return -99.30%
5-Year Return -99.94%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 86.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.45 on 05/14/25
Next Earnings Date 05/13/26 [--]
Earnings Per Share ttm -5.04
EPS Growth vs. Prev Qtr -316.42%
EPS Growth vs. Prev Year -481.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.249 on 03/07/08
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 05/17/23

LADX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -4.26
Interest Coverage -0.44
60-Month Beta 0.77
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.